Structured medication reviews: progress since 2020 and opportunities for improvement.
作者信息
Huang Yun-Ting, Bartlett Jennifer, Lamptey-Parry Mae, Chen Li-Chia
机构信息
Centre for Health Informatics, Division of Informatics, Imaging and Data Science, The University of Manchester; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, The University of Manchester, Manchester.
Service Lead - Network Integrated Practice Pharmacy team in Salford (NIPPS) Team, Northern Care Alliance NHS Foundation Trust, Salford.
出版信息
Br J Gen Pract. 2024 Dec 26;75(750):6-8. doi: 10.3399/bjgp25X740385. Print 2025 Jan.
Abstract
摘要
相似文献
1
Structured medication reviews: progress since 2020 and opportunities for improvement.结构化药物评估：2020年以来的进展与改进机遇
Br J Gen Pract. 2024 Dec 26;75(750):6-8. doi: 10.3399/bjgp25X740385. Print 2025 Jan.
2
How effects on health equity are assessed in systematic reviews of interventions.在干预措施的系统评价中如何评估对健康公平性的影响。
Cochrane Database Syst Rev. 2022 Jan 18;1(1):MR000028. doi: 10.1002/14651858.MR000028.pub3.
3
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.临床有效性和成本效益的连续皮下胰岛素输注治疗糖尿病: 系统评价和经济评估。
Health Technol Assess. 2010 Feb;14(11):iii-iv, xi-xvi, 1-181. doi: 10.3310/hta14110.
4
An Interdisciplinary Dashboard to Streamline Medication Processing at Patient Discharge: A Quality Improvement Initiative.一个用于简化患者出院时药物处理流程的跨学科仪表盘：一项质量改进计划。
Mil Med. 2021 Dec 24. doi: 10.1093/milmed/usab526.
5
Incidence of opportunities for improvement in trauma patient care: a retrospective registry-based study.创伤患者护理改进机会的发生率：一项基于回顾性登记的研究。
Trauma Surg Acute Care Open. 2025 May 22;10(2):e001676. doi: 10.1136/tsaco-2024-001676. eCollection 2025.
6
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study.自加强疫苗接种以来的时间与新冠病毒相关哮喘加重的新冠病毒疾病严重程度及风险：来自英国COVIDENCE研究数据的纵向分析
BMJ Open Respir Res. 2025 May 15;12(1):e003158. doi: 10.1136/bmjresp-2025-003158.
7
Medication review in hospitalised patients to reduce morbidity and mortality.住院患者的药物审查以降低发病率和死亡率。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD008986. doi: 10.1002/14651858.CD008986.pub4.
8
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂（GLP-1 RAs）减肥效果的网状Meta分析的数量、质量及结果：一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
9
A simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management.
Res Social Adm Pharm. 2025 Nov;21(11):904-913. doi: 10.1016/j.sapharm.2025.06.006. Epub 2025 Jun 19.
10
Consensus-based development and practice testing of a generic quality indicator set for parenteral medication administration at home: a RAND appropriateness method study.基于共识的居家肠外给药通用质量指标集的开发与实践测试：一项兰德适宜性方法研究
BMJ Open. 2025 Jul 1;15(7):e090496. doi: 10.1136/bmjopen-2024-090496.
本文引用的文献
1
Association between continuity of primary care and both prescribing and adherence of common cardiovascular medications: a cohort study among patients in England.初级保健连续性与常见心血管药物的开具和依从性之间的关联：英格兰患者的队列研究。
BMJ Open. 2022 Sep 13;12(9):e063282. doi: 10.1136/bmjopen-2022-063282.
2
Early implementation of the structured medication review in England: a qualitative study.英格兰结构化药物审查的早期实施：一项定性研究。
Br J Gen Pract. 2022 Apr 20;72(722):e641-8. doi: 10.3399/BJGP.2022.0014.
3
Structured medication reviews: origins, implementation, evidence, and prospects.结构化药物评估：起源、实施、证据及前景
Br J Gen Pract. 2021 Jul 29;71(709):340-341. doi: 10.3399/bjgp21X716465. Print 2021 Aug.
4
Impact of multimorbidity on healthcare costs and utilisation: a systematic review of the UK literature.多病症对医疗保健成本和利用的影响：英国文献的系统评价。
Br J Gen Pract. 2020 Dec 28;71(702):e39-e46. doi: 10.3399/bjgp20X713897. Print 2021 Jan.
Zotero 插件